NSAID Use Correlates with Reduced PD Risk (Movement Disorders Congress 2002)

Subject: NSAID Use Correlates with Reduced PD Risk (Movement Disorders Congress 2002)

Date: 11/27/2002

E-MOVE reports from the Seventh International Congress of Parkinson’s Disease and Movement Disorders, November 10-14 in Miami, Florida. Poster (P), platform session (PL), and page numbers are from Movement Disorders 2002;17(suppl 5).

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease
H Chen, SM Zhang, MA Hernan, MA Schwarzchild, WC Willett, GA Colditz
P442;S143

Use of NSAIDs is associated with reduced risk of Parkinson's disease, according to this report.

Use of aspirin and other NSAIDs, and incidence of PD, was assessed in over 140,000 subjects in the Health Professionals Follow-up Study and the Nurses' Health Study. A total of 418 cases of PD were identified. After adjustment for caffeine, smoking, and alcohol use, NSAID users had a relative risk of 0.55 (95% CI 0.31-0.95, p=0.03) with a trend toward dose-dependent reduction.
----

2002 E-MOVE conference reports are made possible in part through unrestricted educational grants from these sponsors:
Gold Level: Bertek Pharmaceuticals, Elan Pharmaceuticals, Pharmacia Corporation.
Silver Level: GlaxoSmithKline, Amarin Pharmaceuticals
Bronze Level: Procter & Gamble Pharmaceuticals, Schwarz Pharma.

E-MOVE Editor: Richard Robinson, NASW, WE MOVE

Related CME Activities - Valid for AMA PRA Category 1 Credits(s)™